Premium
Expression of chemerin in the synovial fluid of patients with temporomandibular joint disorders
Author(s) -
Şimşek Kaya G.,
Yapıcı Yavuz G.,
Kızıltunç A.
Publication year - 2018
Publication title -
journal of oral rehabilitation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.991
H-Index - 93
eISSN - 1365-2842
pISSN - 0305-182X
DOI - 10.1111/joor.12608
Subject(s) - chemerin , pathogenesis , synovial fluid , osteoarthritis , medicine , temporomandibular joint , temporomandibular disorder , temporomandibular joint disorder , endocrinology , gastroenterology , pathology , adipokine , insulin resistance , alternative medicine , insulin
Summary The synovial membrane and fluid are significantly involved in the pathogenesis of temporomandibular joint ( TMJ ) disorders. This study aimed to investigate the relation between levels of chemerin in the synovial fluid ( SF ) of patients with TMJ disorder and their relationship. Sixty samples of SF were obtained from patients with an internal derangement ( ID ) or osteoarthritis ( OA ). Chemerin in the SF was examined by enzyme‐linked immunosorbent assay ( ELISA ). The results showed greater levels of chemerin in the SF of patients with OA than ID . While chemerin levels were positively correlated with pain scores, they were inversely correlated with MMO . Chemerin levels increased progressively as the disorder stage became more severe. The findings of this study suggest that chemerin in SF may play role as a predisposing factor and may represent a novel potential prognostic biochemical marker in the pathogenesis of TMJ disorders.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom